Aligos Therapeutics partners with Xiamen Amoytop for liver disease treatment using oligonucleotide platform

Under the terms of the agreement, Aligos and Amoytop will collaborate on the research and development of oligonucleotide compounds for the treatment of liv...

May 15, 2023 | Monday | News
Varian and Siemens Healthineers exhibit cancer care solutions at ESTRO 2023

As a Siemens Healthineers company, Varian is working to connect the cancer care continuum to empower clinicians to deliver more efficient, more personalize...

May 12, 2023 | Friday | News
UCB and Ariceum Therapeutics Partner for Immune-Related Disease and Cancer Treatment Research

UCB's expertise in macrocyclic peptide discovery, using its proprietary mRNA-display platform, ExtremeDiversity™, will aid Ariceum's discovery of t...

May 11, 2023 | Thursday | News
Bayer and Bicycle Therapeutics Partner for Targeted Radionuclide Therapies in Oncology

Collaboration will leverage Bicycle Therapeutic’s synthetic peptides for the discovery and development of multiple targeted radioconjugates of the ...

May 11, 2023 | Thursday | News
Thermo Fisher and Pfizer join forces to expand Cancer Testing in Global Markets

Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access...

May 10, 2023 | Wednesday | News
China Approves KN026 + Chemotherapy Phase III Study for Breast Cancer Treatment

Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. jointly announced that the IND application was approved in China for t...

May 09, 2023 | Tuesday | News
Singlera Genomics' PDACatch Gets FDA Breakthrough Designation for Pancreatic Cancer Liquid Biopsy

Pancreatic adenocarcinoma (PDAC) is one of the most deadly forms of cancer, in part due to the majority of diagnoses being late-stage; the five-year surviv...

May 09, 2023 | Tuesday | News
New ACR Breast Cancer Screening Guidelines call for earlier and more-intensive screening for high-risk women

Other Notable Updates:   New American College of Radiology® (ACR®) breast cancer screening guidelines now call for all women &mdas...

May 04, 2023 | Thursday | News
China Phase II Clinical Study of Osemitamab Completes Enrollment for First-Line Gastric Cancer Treatment

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...

May 03, 2023 | Wednesday | News
EirGenix's EG1206A Meets Phase 1 Trial Objectives as Breast Cancer Biosimilar

EG1206A is a biosimilar drug of the second-generation HER2-positive antibody drug Perjeta® (pertuzumab). EG1206A has a unique binding mechanism for HER...

May 03, 2023 | Wednesday | News
Genomic Urine Test Detects Bladder Cancer from DNA Up to 12 Years Before Clinical Signs and Symptoms Appear

A new genomic urine test can help doctors accurately predict bladder cancer as many as 12 years before clinical signs and symptoms emerge and long before a...

May 02, 2023 | Tuesday | News
Curasight and Curium announce global partnership for uTRACE® in prostate cancer

Curasight to develop its proprietary uTRACE® PET imaging technology to obtain regulatory approval in EU and USA, with Curium responsible for man...

May 02, 2023 | Tuesday | News
Rakovina Therapeutics Inc. Announces 2022 Financial Results and Convertible Debenture Financing

Rakovina Therapeutics also announced that it will issue approximately thirty (30) unsecured $50,000 convertible debenture units to a select group of i...

May 02, 2023 | Tuesday | Company results
Could Tumoroids Solve the Problem of High Attrition in Cancer Trials?

There is growing recognition that the experimental model systems used in many cancer research projects, which include 2D cell cultures, patient-derived xen...

May 01, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close